BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 2487253)

  • 1. Immunomagnetic T-lymphocyte depletion (ITLD) of rat bone marrow using OX-19 monoclonal antibody.
    Hoffman AL; Makowka L; Cramer DV; Cai X; Pascualone A; Banner BF; Sheahan DG; Rettinger P; Starzl TE
    J Invest Surg; 1989; 2(3):241-51. PubMed ID: 2487253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T-cell depletion of allogeneic bone marrow using anti-alphabetaTCR monoclonal antibody: prevention of graft-versus-host disease without affecting engraftment potential in rats.
    Neipp M; Exner BG; Maru D; Haber M; Gammie JS; Pham SM; Ildstad ST
    Exp Hematol; 1999 May; 27(5):860-7. PubMed ID: 10340402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of stable chimerism and elimination of graft-versus-host disease by depletion of T lymphocytes from bone marrow using immunomagnetic beads.
    Hoffman AL; Makowka L; Cramer DV; Cai X; Banner B; Pascualone A; Hoffmann S; Starzl TE
    Surgery; 1989 Aug; 106(2):354-63. PubMed ID: 2669198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T-cell depletion of human bone marrow.
    Gee AP; Mansour V; Weiler M
    J Immunogenet; 1989 Apr; 16(2):103-15. PubMed ID: 2687381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal antibodies for the prevention of graft-versus-host disease and marrow graft rejection. The depletion of T cell subsets in vitro and in vivo.
    Cobbold S; Martin G; Waldmann H
    Transplantation; 1986 Sep; 42(3):239-47. PubMed ID: 3529524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of donor mice with an alpha beta T-cell receptor monoclonal antibody induces prolonged T-cell nonresponsiveness and effectively prevents lethal graft-versus-host disease in murine recipients of major histocompatibility complex (MHC)-matched and MHC-mismatched donor marrow grafts.
    Drobyski WR; Majewski D
    Blood; 1996 Jun; 87(12):5355-69. PubMed ID: 8652851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T lymphocyte depletion of human peripheral blood and bone marrow using monoclonal antibodies and magnetic microspheres.
    Gee AP; Lee C; Sleasman JW; Madden M; Ugelstad J; Barrett DJ
    Bone Marrow Transplant; 1987 Aug; 2(2):155-63. PubMed ID: 2901878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of graft-versus-host disease in DLA-haplotype mismatched dogs and hemopoietic engraftment of CD6-depleted marrow with and without cG-CSF treatment after transplantation.
    Schumm M; Günther W; Kolb HJ; Rieber P; Büttner M; Voss C; Kremmer E; Reitmeier P; Thierfelder S; Wilmanns W
    Tissue Antigens; 1994 Mar; 43(3):170-8. PubMed ID: 7522357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo or in vitro anti-CD3 epsilon chain monoclonal antibody therapy for the prevention of lethal murine graft-versus-host disease across the major histocompatibility barrier in mice.
    Blazar BR; Taylor PA; Vallera DA
    J Immunol; 1994 Apr; 152(7):3665-74. PubMed ID: 8144942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Depletion of T lymphocytes from human bone marrow. Use of magnetic monosized polymer microspheres coated with T-lymphocyte-specific monoclonal antibodies.
    Vartdal F; Kvalheim G; Lea TE; Bosnes V; Gaudernack G; Ugelstad J; Albrechtsen D
    Transplantation; 1987 Mar; 43(3):366-71. PubMed ID: 3103274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T cell depletion with anti-CD5 immunotoxin in histocompatible bone marrow transplantation. The correlation between residual CD5 negative T cells and subsequent graft-versus-host disease.
    Filipovich AH; Vallera D; McGlave P; Polich D; Gajl-Peczalska K; Haake R; Lasky L; Blazar B; Ramsay NK; Kersey J
    Transplantation; 1990 Sep; 50(3):410-5. PubMed ID: 1698319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new marrow T cell depletion method using anti-CD6 monoclonal antibody-conjugated magnetic beads and its clinical application for prevention of acute graft-vs.-host disease in allogeneic bone marrow transplantation: results of a phase I-II trial.
    Sao H; Kitaori K; Kasai M; Shimokawa T; Kato C; Yamanishi H; Ueda R; Morishima Y
    Int J Hematol; 1999 Jan; 69(1):27-35. PubMed ID: 10641440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T-cell depleting antibodies: new hope for induction of allograft tolerance in bone marrow transplantation?
    Simpson D
    BioDrugs; 2003; 17(3):147-54. PubMed ID: 12749751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin 2 prevents graft-versus-host disease while preserving the graft-versus-leukemia effect of allogeneic T cells.
    Sykes M; Romick ML; Sachs DH
    Proc Natl Acad Sci U S A; 1990 Aug; 87(15):5633-7. PubMed ID: 2377601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a simplified counterflow centrifugation elutriation procedure for depletion of lymphocytes from human bone marrow.
    Noga SJ; Donnenberg AD; Schwartz CL; Strauss LC; Civin CI; Santos GW
    Transplantation; 1986 Feb; 41(2):220-9. PubMed ID: 2935979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T cell depletion from human bone marrow using magnetic beads.
    Knobloch C; Spadinger U; Rueber E; Friedrich W
    Bone Marrow Transplant; 1990 Jul; 6(1):21-4. PubMed ID: 2390629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of graft-versus-host reactivity, lymphocyte depletion, and cell dose on allogeneic bone marrow engraftment.
    Glass B; Uharek L; Gaska T; Gassmann W; Löffler H; Müller-Ruchholtz W
    Bone Marrow Transplant; 1993; 12 Suppl 3():S41-7. PubMed ID: 8124257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of rotor off fraction in allogeneic murine bone marrow transplantation with complete disparity of major histocompatibility.
    Jeong DC; Han CW; Jin JY; Kim DS; Choi IB; Kim WI; Kim HK; Kim CC; Lee BC; Imamura M; Noga SJ
    Exp Hematol; 1999 Jul; 27(7):1219-25. PubMed ID: 10390198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimizing chimerism level through bone marrow transplantation and irradiation to induce long-term tolerance to composite tissue allotransplantation.
    Lin JY; Tsai FC; Wallace CG; Huang WC; Wei FC; Liao SK
    J Surg Res; 2012 Nov; 178(1):487-93. PubMed ID: 22484382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Graft-versus-host disease prevention in allogeneic bone marrow transplantation from histocompatible siblings. A pilot study using immunotoxins for T cell depletion of donor bone marrow.
    Filipovich AH; Vallera DA; Youle RJ; Haake R; Blazar BR; Arthur D; Neville DM; Ramsay NK; McGlave P; Kersey JH
    Transplantation; 1987 Jul; 44(1):62-9. PubMed ID: 3299923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.